PWRM.OB, NYSE:DGX, NYSE:JNJ, Medical Updates from Stock-PR.com
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________
Power3 Medical Products, Inc. (PWRM.OB) announced today that Helen R. Park, Power3’s Chief Executive Officer, presented a “State of the Company” report to a sell-out crowd at the Economic Development Partners luncheon held this past Tuesday, May 11, 2010 at the Woodlands Resort and Conference Center. Ms. Park was the lead speaker at the event and was joined by several other notable speakers, including Joseph Podolski, President and CEO of Repros Therapeutics Arthur T. Sands, President and CEO of Lexicon Pharmaceuticals , and Neil Warma, President and CEO of Opexa Therapeutics. The report provided by Ms. Park was very similar to those recently presented by Bill Gates of Microsoft Corp and Warren Buffet of Berkshire Hathaway to members of the public.
Each of the presenters described the difficulties they have encountered during the recent economic downturn and the steps that they took to ensure their survival. They also described the current status of their technologies in the clinical trial lifestyle and their plans for these products once they reach commercialization. “Power3 has taken a hard line approach to manage the resources and secure new capital to survive the economic down turn,” stated Ms. Park. “We are delighted to be actively moving forward with our clinical trials for our Alzheimer’s disease diagnostic tests and Parkinson’s disease diagnostic tests. We have implemented a lean and mean approach to our work and the commercialization of our products which is serving us very well at the present time.”
Quest Diagnostics Incorporated (NYSE: DGX) has been awarded its 2010 Best Employers for Healthy Lifestyles Platinum Award. The 2010 award, in recognition Quest Diagnostics’ HealthyQuest employee wellness initiative, marks the second consecutive year Quest Diagnostics has earned the prestigious Platinum distinction, the NBGH’s highest honor.Quest Diagnostics was honored with Gold Awards in 2008 and 2007 and Silver Awards in 2006 and 2005, and is one of only six companies to earn NBGH Best Employer recognition in each year of the program since its inception.
Since 2005, the Quest Diagnostics HealthyQuest employee wellness initiative has focused on fostering a workplace culture that encourages healthy behaviors, and has helped Quest Diagnostics employees to measurably lower their health risks by adopting healthier lifestyles. At the heart of the HealthyQuest program is Quest Diagnostics’ Blueprint for Wellness(TM) health risk assessment service, which includes a panel of up to 30 laboratory tests. The service is available at no charge to 42,000 domestic employees as well as their spouses or domestic partners. Each Blueprint for Wellness participant receives a patient-friendly report that includes laboratory test results, a health assessment and a health quotient score. An optional PSA test for the early detection of prostate cancer is offered as part of the Blueprint for Wellness service, and employees, spouses, and domestic partners age 50 and older are offered the InSure(R) FIT(TM) fecal immunochemical test for colorectal cancer screening, 6,000 of which completed the test in 2009.
Johnson & Johnson (NYSE: JNJ) makes a big difference in the health and well-being of people every day. Johnson & Johnson have more than 250 operating companies in 57 countries employing approximately 114,000 people. Johnson & Johnson’s consumer products, prescription medicines and medical devices and diagnostics impact the state of health care for patients, doctors, and nurses around the world.
Every day, millions of people around the world enjoy the benefits of products from the Johnson & Johnson Family of Companies. Very likely, someone in your family is one of them. Your family’s health and well-being is our passion. That’s why Johnson & Johnson companies offer the world’s broadest range of health care products. Whether you have a skin blemish or sniffles or a serious medical condition, you and the health professionals you trust can turn to Johnson & Johnson’s products for comfort and care. In your home, products from Johnson & Johnsons consumer health companies brighten your smile, add luster to your hair and ease that nagging headache. You can rely on Johnson & Johnson to help keep baby fresh, sooth an irritating itch, or relieve an aching muscle. In operating rooms and laboratories, doctors and nurses, too, rely on products from Johnson & Johnson medical technology companies. They use these products to perform hip replacements, implant coronary stents, and run tests for metastatic breast cancer that give people hope for a longer, more active life. These products help them help people conquer life-threatening obesity, ward off colon cancer, and control their diabetes. The list goes on. Whatever your family’s health care needs, the Johnson & Johnson Family of Companies is at your side.
Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading shares for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________
Be Sure To Visit stock-pr.ning.com
********************************
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
